Actively Recruiting

Phase Not Applicable
Age: 50Years - 74Years
FEMALE
Healthy Volunteers
NCT05800132

Diagnostic Performance of Breast Cancer Screening Second Reading Process Assisted by AI

Led by Therapixel · Updated on 2024-04-12

5000

Participants Needed

7

Research Sites

221 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to compare, for the second reading of screening mammograms, the standard of care with an AI assisted scenario. The main questions it aims to answer are: * will the experimental pathway be non-inferior to the standard pathway? * will the experimental pathway be economically superior to the standard pathway? Participants will receive screening mammograms, as part of the breast cancer screening program. Researchers will compare the interpretation made by the second reader in the standard pathway with the AI assisted interpretation made by a different reader in the experimental pathway.

CONDITIONS

Official Title

Diagnostic Performance of Breast Cancer Screening Second Reading Process Assisted by AI

Who Can Participate

Age: 50Years - 74Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Female participants aged between 50 and 74 years
  • Affiliated with the French social security system
  • Mammograms must include 4 images (2 per breast, CC and MLO) meeting local regulatory standards with correct DICOM metadata
  • Mammograms previously read as normal or benign lesions by the first radiologist in the screening program
  • Willing to participate, undergo all procedures, and be available for the study duration
  • Completed and signed informed consent form
Not Eligible

You will not qualify if you...

  • Women with breast implants
  • Women showing clinical symptoms of breast cancer
  • History of breast surgery such as breast reduction or surgery for benign lesions
  • Pregnant or breastfeeding women
  • Medical conditions preventing understanding of the study or giving informed consent
  • Women deprived of liberty by judicial or administrative order
  • Mammogram images with defects such as poor quality, non-standard mammography types, or specific unsupported views (ML/LM/SIO/XCCL or XCCM)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 7 locations

1

Centre de radiologie Les Défensions

Aubagne, France

Actively Recruiting

2

Var Imagerie Medicale

Draguignan, France

Actively Recruiting

3

VAR IMAGERIE MEDICALE - Centre d'Imagerie Médicale Le Clipper

Fréjus, France

Actively Recruiting

4

VAR IMAGERIE MEDICALE - Clinique Les Lauriers

Fréjus, France

Actively Recruiting

5

Cabinet de Radiologie du Cabot

Marseille, France

Completed

6

Centre de Sénologie Mermoz

Marseille, France

Actively Recruiting

7

VAR IMAGERIE MEDICALE - Centre d'Imagerie Médicale Epsilon

Saint-Raphaël, France

Actively Recruiting

Loading map...

Research Team

B

Brigitte Seradour

CONTACT

P

Patrice Heid

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

CROSSOVER

Primary Purpose

SCREENING

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here